Jupiter Drugs & Medical Supls is categorized under in Jupiter, FL and active since 1997.
Jupiter Drugs & Medical Supls was established in 1997, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Barry Sternburg, Owner at the company’s single location by writing to 1025 Military Trail # 100, Jupiter, Florida FL 33458 or by phoning (561) 746-7499. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Jupiter Drugs & Medical Supls |
| Contact Person: | Barry Sternburg, Owner |
| Address: | 1025 Military Trail # 100, Jupiter, Florida 33458 |
| Phone Number: | (561) 746-7499 |
| Website Address: | jupiterdrugs.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 4461100 |
| Share This Business: |
Jupiter Drugs & Medical Supls was started in 1997 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Barry Sternburg, Owner for inquiries that concern Jupiter Drugs & Medical Supls by calling the company number (561) 746-7499, as your correspondence is most welcome. Additionally, the physical location of the single location of Jupiter Drugs & Medical Supls can be found at the coordinates 26.92279,-80.10199 as well as the street address 1025 Military Trail # 100 in Jupiter, Florida 33458.
For its online presence, you may visit Jupiter Drugs & Medical Supls’s website at jupiterdrugs.com and engage with its social media outlets through on Twitter and on Facebook.